Andrew A. Ziskind

Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.

Ik‐Kyung Jang, Herman K. Gold, Andrew A. Ziskind et al. · Circulation · 1989 · 555 citations

Medicine, Cardiology, Pharmacology +17

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.

Herman K. Gold, Barry S. Coller, Tsunehiro Yasuda et al. · Circulation · 1988 · 393 citations

Medicine, Cardiology, Pharmacotherapy +15

Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: Description of technique and report of the first 50 cases

Andrew A. Ziskind, A. C. Pearce, Cyndi C. Lemmon et al. · Journal of the American College of Cardiology · 1993 · 178 citations

Medicine, Cardiology, Surgery +7

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.

Ik‐Kyung Jang, Herman K. Gold, Andrew A. Ziskind et al. · Circulation · 1990 · 175 citations

Medicine, Pharmacology, Pharmacotherapy +17

Percutaneous balloon pericardial window for patients with malignant pericardial effusion and tamponade

Igor F. Palacios, E. Murat Tuzcu, Andrew A. Ziskind et al. · Catheterization and Cardiovascular Diagnosis · 1991 · 107 citations

Medicine, Cardiology, Surgery +14